{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:29:47Z","timestamp":1761092987179,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.urolonc.2011.02.003","type":"journal-article","created":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T02:00:41Z","timestamp":1301623241000},"page":"372-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["TGF-B1 pathway as biological marker of bladder carcinoma schistosomal and non-schistosomal"],"prefix":"10.1016","volume":"31","author":[{"given":"Olfat","family":"Shaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olfat","family":"Hammam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Wishahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamdouh","family":"Roshdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2002","series-title":"National Cancer Institute registry the national cancer registry newsletter","key":"10.1016\/j.urolonc.2011.02.003_bib1"},{"key":"10.1016\/j.urolonc.2011.02.003_bib2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-5347(17)35014-0","article-title":"Review of chromosome studies in urological tumors","volume":"151","author":"Sandberg","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.02.003_bib3","unstructured":"Mokhtar N, Gouda I, Adel I. Malignant urinary system tumors. In: Cancer Pathology Registry (2003\u20132004) and Time Trend Analysis, Chapter 3. Department of Pathology NCI, Cairo, Egypt. [Chapter 3] p. 32\u20138."},{"key":"10.1016\/j.urolonc.2011.02.003_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10555-006-9006-2","article-title":"Transforming growth factor-b in cancer metastasis","volume":"25","author":"Jakowlew","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.urolonc.2011.02.003_bib5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrc1926","article-title":"Tumor microenvironment: Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer","volume":"6","author":"Bierie","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2011.02.003_bib6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0092-8674(93)90489-D","article-title":"Cloning of TGF-\u00df type I receptor that forms a heteromeric complex with the TGF-\u00df type II receptor","volume":"75","author":"Franzen","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2011.02.003_bib7","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1073\/pnas.92.5.1565","article-title":"Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor-\u00df receptor kinase","volume":"92","author":"Chen","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2011.02.003_bib8","first-page":"873","article-title":"The transforming growth factor-\u00df: Structural features, and mechanisms of activation","volume":"147","author":"Munger","year":"1995","journal-title":"Am J Path"},{"key":"10.1016\/j.urolonc.2011.02.003_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/1097-4652(200002)186:2<153::AID-JCP1016>3.0.CO;2-J","article-title":"Role of transforming growth factor-\u00df in cancer","volume":"186","author":"Pasche","year":"2001","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.urolonc.2011.02.003_bib10","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0022-5347(01)65670-2","article-title":"Transforming growth factors-\u00df1 and \u00df2 in serum and urine from patients with bladder carcinoma","volume":"156","author":"Eder","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.02.003_bib11","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/1097-0142(20010915)92:6<1475::AID-CNCR1472>3.0.CO;2-X","article-title":"Predictive value of expression of transforming growth factor \u00df1, and its receptors in transitional cell carcinoma of the urinary bladder","volume":"92","author":"Kim","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2011.02.003_bib12","first-page":"921","article-title":"Overexpression of transforming growth factor \u00df type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line","volume":"8","author":"Okamoto","year":"1997","journal-title":"Cell Growth Differ"},{"year":"2004","series-title":"World Health Organization classification of tumors","author":"Eble","key":"10.1016\/j.urolonc.2011.02.003_bib13"},{"key":"10.1016\/j.urolonc.2011.02.003_bib14","doi-asserted-by":"crossref","first-page":"8772","DOI":"10.1073\/pnas.91.19.8772","article-title":"Genetic changes in transforming growth factor-\u00df (TGF-\u00df) type II receptor gene in human gastric cancer cell: Correlation with sensitivity to growth inhibition by TGF-\u00df","volume":"91","author":"Park","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2011.02.003_bib15","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.7761852","article-title":"Inactivation of the type II TGF-\u00df receptor in colon cancer cells with microsatellite instability","volume":"268","author":"Markowitz","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2011.02.003_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cytogfr.2005.09.009","article-title":"Alterations in components of the TGF-b superfamily signaling pathways in human cancer","volume":"17","author":"Levy","year":"2006","journal-title":"Cytokine Growth Factors Rev"},{"key":"10.1016\/j.urolonc.2011.02.003_bib17","doi-asserted-by":"crossref","first-page":"22044","DOI":"10.1074\/jbc.270.37.22044","article-title":"Demonstration that mutation of type II TGF-\u00df receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells","volume":"220","author":"Wang","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2011.02.003_bib18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0046-8177(99)90110-7","article-title":"Expression of transforming growth factor \u00df1 and its receptors in normal human urothelium and human transitional cell carcinomas","volume":"30","author":"Izadifar","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2011.02.003_bib19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1083\/jcb.111.2.731","article-title":"Transforming growth factor \u00df1-induced changes on cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane","volume":"111","author":"Yang","year":"1990","journal-title":"J Cell Biol"},{"key":"10.1016\/j.urolonc.2011.02.003_bib20","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1073\/pnas.83.12.4167","article-title":"Transforming growth factor type \u00df: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro","volume":"83","author":"Roberts","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2011.02.003_bib21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0094-0143(21)00435-3","article-title":"Molecular genetics and biochemical mechanisms in bladder cancer","volume":"19","author":"Sidransky","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2011.02.003_bib22","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0022-5347(01)67516-5","article-title":"Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy","volume":"153","author":"Steiner","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.02.003_bib23","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/1097-0142(19950515)75:10<2565::AID-CNCR2820751025>3.0.CO;2-M","article-title":"Expression of TGF-b1 in human bladder cancer","volume":"75","author":"Miyamoto","year":"1995","journal-title":"Cancer"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143911000470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143911000470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:59:41Z","timestamp":1761040781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143911000470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1078143911000470"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2011.02.003","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TGF-B1 pathway as biological marker of bladder carcinoma schistosomal and non-schistosomal","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2011.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}